Silver Book Fact

U.S. spending on cancer treatment has risen greatly over time, from $13.1 billion in 1980 to $72.1 billion in 2004. 

Phillipson, Thomas, Michael Eber, Darius N. Lakdawalla, Mitra Corral, Rena Conti, and Dana P. Goldman. An Analysis Of Whether Higher Health Care Spending In The United States Versus Europe Is ‘Worth It’ In The Case of Cancer. Health Affairs. 2012; 31(4): 667-675

Reference

Title
An Analysis Of Whether Higher Health Care Spending In The United States Versus Europe Is ‘Worth It’ In The Case of Cancer
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2012
Authors
Phillipson, Thomas, Michael Eber, Darius N. Lakdawalla, Mitra Corral, Rena Conti, and Dana P. Goldman
Volume & Issue
Volume 31, Issue 4
Pages
667-675

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Following the current path, the lung cancer incidence rate will increase by 34% between 2003 and 2023.  
  • In 2015, an estimated 221,200 new cases of lung cancer are expected to be diagnosed.  
  • In 2007, an estimated 180,510 people (2,030 men and 178,480 women) will be diagnosed with breast cancer.  
  • Net patient time costs during the initial phase of care ranged from $271 and $842 for melanoma of the skin and prostate cancer, respectively, to $5348 and $5605 for gastric…  
  • Cancer is the highest-cost diagnosis in terms of out-of-pocket spending.